BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 37179446)

  • 21. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma.
    Huang H; Ren Z; Gao X; Hu X; Zhou Y; Jiang J; Lu H; Yin S; Ji J; Zhou L; Zheng S
    Genome Med; 2020 Nov; 12(1):102. PubMed ID: 33225985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection.
    Romani L; Del Chierico F; Macari G; Pane S; Ristori MV; Guarrasi V; Gardini S; Pascucci GR; Cotugno N; Perno CF; Rossi P; Villani A; Bernardi S; Campana A; Palma P; Putignani L;
    Front Cell Infect Microbiol; 2022; 12():908492. PubMed ID: 35873161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microbiota dysbiosis in Chinese children with type 1 diabetes mellitus: An observational study.
    Liu X; Cheng YW; Shao L; Sun SH; Wu J; Song QH; Zou HS; Ling ZX
    World J Gastroenterol; 2021 May; 27(19):2394-2414. PubMed ID: 34040330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Characteristics of intestinal flora in patients with primary Sjögren syndrome].
    Wang X; Wang J; Guo W; Zhou Y; Sun C; Li Z; Chen L; Pan X
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul; 40(7):949-957. PubMed ID: 32895147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations of the Gut Microbiota in Hashimoto's Thyroiditis Patients.
    Zhao F; Feng J; Li J; Zhao L; Liu Y; Chen H; Jin Y; Zhu B; Wei Y
    Thyroid; 2018 Feb; 28(2):175-186. PubMed ID: 29320965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
    Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
    [No Abstract]   [Full Text] [Related]  

  • 27. Dysbiosis of gut microbiota in patients with esophageal cancer.
    Deng Y; Tang D; Hou P; Shen W; Li H; Wang T; Liu R
    Microb Pathog; 2021 Jan; 150():104709. PubMed ID: 33378710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of Gut Microbiota in Patients with GH-Secreting Pituitary Adenoma.
    Lin B; Wang M; Gao R; Ye Z; Yu Y; He W; Qiao N; Ma Z; Ji C; Shi C; Zhou X; Wang Y; Zeng F; Zhang L; Gong W; Cao Z; Zhou P; Melnikov V; Ye H; Li Y; Zhang Z; He M; Qin H; Zhang Y
    Microbiol Spectr; 2022 Feb; 10(1):e0042521. PubMed ID: 35019688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysbiosis signatures of gut microbiota in coronary artery disease.
    Zhu Q; Gao R; Zhang Y; Pan D; Zhu Y; Zhang X; Yang R; Jiang R; Xu Y; Qin H
    Physiol Genomics; 2018 Oct; 50(10):893-903. PubMed ID: 30192713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbial signatures of patients with primary hepatocellular carcinoma and their healthy first-degree relatives.
    Feng J; Wu Y; Dai P; Wang D; Liu L; Chai B
    J Appl Microbiol; 2023 Oct; 134(10):. PubMed ID: 37777841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of gut microbiota alterations in Alzheimer's dementia patients from Kazakhstan.
    Kaiyrlykyzy A; Kozhakhmetov S; Babenko D; Zholdasbekova G; Alzhanova D; Olzhayev F; Baibulatova A; Kushugulova AR; Askarova S
    Sci Rep; 2022 Sep; 12(1):15115. PubMed ID: 36068280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy.
    Dong R; Bai M; Zhao J; Wang D; Ning X; Sun S
    Front Cell Infect Microbiol; 2020; 10():557368. PubMed ID: 33194798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal microecology in mice bearing diethylnitrosamine-induced primary hepatocellular carcinoma.
    Zhou W; Zheng Y; Shang J; Wang H; Wang Y; Lu H; Wang X; Sui M
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 51(4):438-453. PubMed ID: 37202098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma.
    Piñero F; Vazquez M; Baré P; Rohr C; Mendizabal M; Sciara M; Alonso C; Fay F; Silva M
    Ann Hepatol; 2019; 18(3):480-487. PubMed ID: 31023615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower human defensin 5 in elderly people compared to middle-aged is associated with differences in the intestinal microbiota composition: the DOSANCO Health Study.
    Shimizu Y; Nakamura K; Kikuchi M; Ukawa S; Nakamura K; Okada E; Imae A; Nakagawa T; Yamamura R; Tamakoshi A; Ayabe T
    Geroscience; 2022 Apr; 44(2):997-1009. PubMed ID: 34105106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of gastric cancer gut microbiome according to tumor stage and age segmentation.
    Chen C; Du Y; Liu Y; Shi Y; Niu Y; Jin G; Shen J; Lyu J; Lin L
    Appl Microbiol Biotechnol; 2022 Oct; 106(19-20):6671-6687. PubMed ID: 36083304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlations between Intestinal Microbiota and Clinical Characteristics in Colorectal Adenoma/Carcinoma.
    Lin C; Li B; Tu C; Chen X; Guo M
    Biomed Res Int; 2022; 2022():3140070. PubMed ID: 35937408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Short-Term Consumption of Lactic Acid Bacteria on the Gut Microbiota in Obese People.
    Burakova I; Smirnova Y; Gryaznova M; Syromyatnikov M; Chizhkov P; Popov E; Popov V
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma.
    Ren Z; Li A; Jiang J; Zhou L; Yu Z; Lu H; Xie H; Chen X; Shao L; Zhang R; Xu S; Zhang H; Cui G; Chen X; Sun R; Wen H; Lerut JP; Kan Q; Li L; Zheng S
    Gut; 2019 Jun; 68(6):1014-1023. PubMed ID: 30045880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer.
    Deng T; Li J; He B; Chen B; Liu F; Chen Z; Zheng J; Shi Z; Zhang T; Deng L; Yu H; Yang J; Wu L; Shan Y; Yu Z; Chen X; Wang Y; Chen G
    Hepatol Int; 2022 Feb; 16(1):99-111. PubMed ID: 35064546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.